Immunosurveillance and Survivin-Specific T-Cell Immunity in Children With High-Risk Neuroblastoma
Authors:
- 20 December 2006
- journal article
- pediatric oncology
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (36) , 5725-5734
Abstract
Purpose: Tumor immunosurveillance influences oncogenesis and tumor growth, but it remains controversial whether clinical failure of immunosurveillance is a result of lymphocyte dysfunction or tumor escape. In this study, our goal was to characterize the physiology of tumor immunosurveillance in children with high-risk neuroblastoma (HR-NBL).Patients and Methods: Immunohistopathologic studies were carried out on 26 tumor samples from a cohort of HR-NBL patients diagnosed at Children's Hospital of Philadelphia for the 2-year period from May 2003 to May 2005. Blood from nine HLA-A2+patients in this cohort was analyzed for T cells specific for the antiapoptotic protein survivin.Results: Survivin protein was expressed by 26 of 26 tumors. In HLA-A2+patients, circulating cytotoxic T lymphocytes (CTLs) specific for survivin were detected by peptide/major histocompatibility complex tetramer analysis in the blood of eight of nine children with HR-NBL at the time of diagnosis. Rather than being selectively rendered anergic in vivo, circulating survivin-specific CTLs were highly functional as shown by cytotoxicity and interferon gamma enzyme-linked immunospot assays in six of nine patients. Survivin-specific CD107a mobilization by T cells was found in five of five patients. By immunohistochemistry, tumor-infiltrating T cells were few or absent in 26 of 26 tumors.Conclusion: Children with HR-NBL harbor robust cellular immune responses to the universal tumor antigen survivin at the time of diagnosis, but intratumoral T cells are strikingly rare, suggesting a failure of cellular immunosurveillance. Efforts to develop novel therapies that increase T-cell trafficking into tumor nests are warranted.Keywords
This publication has 47 references indexed in Scilit:
- Mechanisms of immune evasion of human neuroblastomaCancer Letters, 2005
- Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemiaBlood, 2005
- Cat and mouse gamesNature, 2005
- Getting to the Surface: A Link Between Tumor Antigen Discovery and Natural Presentation of Peptide-MHC ComplexesClinical Cancer Research, 2005
- Death during induction therapy and first remission of acute leukemia in childhoodCancer, 2004
- The ins and outs of cross-presentationNature Immunology, 2003
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastomaOncogene, 2000
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999